Predictive Technology Group, Inc., through its subsidiary, Predictive Therapeutics, Inc., engages in the commercialization of therapeutics leveraged by proprietary gene-based companion diagnostics for the treatment of serious and debilitating diseases. It primarily offers EndoRisk, a companion diagnostic/genetic test for endometriosis. The company is also developing NHP-07, a pharmaceutical/therapeutic candidate for the treatment of endometriosis; genetic scoliosis test for the diagnosis of scoliosis; and test for degenerative disc disease. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is based in Salt Lake City, Utah.